Plain-English translation of NCT04918095 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
CareCOPD is a home monitoring device designed to help detect early warning signs of COPD flare-ups (called exacerbations) before you might notice them yourself. The study will track 50 patients with moderate to severe COPD for six months, collecting breathing measurements and symptom information to see if the device can spot problems earlier than usual assessment methods.
COPD flare-ups can get serious quickly, and catching them earlier gives patients and doctors a chance to treat them before they become severe enough to need emergency care or hospitalization. This study is testing whether home monitoring technology can give patients and doctors that extra warning time.
You likely qualify if…
You likely don't qualify if…
Over six months, you would use the CareCOPD device at home to regularly measure your breathing and report your symptoms, likely through a smartphone or tablet app. The device performs simple breathing tests (forced oscillometry), and you would answer symptom questions similar to those your doctor may already ask you during regular visits. The study team will track this data to see if the device detects flare-ups earlier than your own assessment would.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
United States
Sponsor
Cognita Labs LLC
Enrollment target
~50 participants
Started
November 2020
Primary completion
May 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
40 Years – 100 Years
Last updated on clinicaltrials.gov in August 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Rajoshi Biswas, Ph.D.
Cognita Labs LLC
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.